Thyroid cancer mortality, thyroid cancer survival rate

Benign thyroid nodules, according to the norms**, do not pose a threat to the survival of patients, while the prognosis of thyroid cancer can vary greatly according to different types, some develop slowly, rarely cause death, and some develop rapidly, with a high mortality rate.

Overall, the earlier the clinical stage, the better the prognosis. The 5-year survival rates for stage, stage, stage, and stage thyroid cancer are ., respectively50% and so.

According to research data, the 5-year and 10-year survival rates of differentiated thyroid cancer are and respectively, which is also the most clinically occurring type (over 90%). The 5-year survival rates for medullary carcinoma and undifferentiated carcinoma are 68% and respectively.

The annual mortality rate of thyroid cancer is relatively low at about 5:1 million, which shows that the prognosis of most simple adenocarcinoma is relatively good, with the lowest mortality rate for people under 50 years old and a sharp increase for people over 50 years old. Thyroid cancer kills 1,490 patients in the United States each year, accounting for all cancer deaths.

Men occupy the rice, and women occupy the rice. Although the incidence of thyroid cancer has gradually increased, the mortality rate has indeed decreased over the past 50 years, and the morning rate has declined, which is due to improvements in early diagnosis and treatment methods and where undifferentiated cancers have occurred, for example, the five-year relative survival rate for thyroid cancer has risen from 80% in 1950 to 1954 to 60% in 1999 in 1992.

The survival rate of thyroid cancer should be analyzed on a case-by-case basis, and it should be judged according to different cancerous conditions, but usually the survival rate of thyroid cancer can reach 80% in 5 years after surgery, but we should also pay attention to maintaining a healthy routine and reducing the possibility of cancer.

The 5-year survival rate for thyroid cancer is 93%. Early detection, early **, strive for**. There are many commonly used methods for thyroid cancer, and the first plan is determined according to the specific situation of the patient and the degree of pathological malignancy, and surgery is generally the main method.

People who have thyroid cancer also want to live, so what is the survival rate of thyroid cancer?

Most thyroid cancers do not endanger the lives of patients because of this disease, and can achieve a long survival time, only some thyroid cancers are undifferentiated thyroid cancers, the disease progresses rapidly, the mortality rate is relatively high, and it is often difficult to survive for more than one year.

Therefore, the thyroid mass should be surgically removed in time, and after surgical resection, the pathological nature should be determined according to the patient's pathological situation, and whether further auxiliary endocrine, radiation, etc. are needed, so as to improve the patient's effect and reduce the probability of metastasis. Thyroid cancer patients should pay attention to regular iodine-containing food intake, pay attention to appropriate physical activity, avoid obesity, reduce staying up late and other lifestyle habits, all of which can reduce the probability of thyroid cancer metastasis.

Thyroid cancer is still terminally ill, so how much do thyroid cancer patients live for?

Compared with other malignant tumors, the prognosis of thyroid cancer is very good. Although it is a malignant tumor, its 20-year survival rate can reach more than 90%, so it needs to be taken seriously. If it occurs, it is recommended to do it as soon as possible**, with surgery as the main focus.

After surgery, pay attention to rest and diet, because of the lack of thyroid gland, it is necessary to actively supplement levothyroxine sodium tablets, and then regular re-examination.

If it is a patient with advanced thyroid cancer, there will usually be lymph node metastasis, and iodine radiation is required after surgery**The survival period is relatively long, usually about 5 years, it should be noted that the type of thyroid cancer is different, the attitude towards the disease is different, and the survival period of the patient will be different.

In recent years, the incidence of thyroid cancer has only increased, and has been at a medium and high level, compared with ten years ago, the incidence of thyroid cancer has increased by three times, which is a terrible set of data, especially in women, female solid tumors have risen the fastest, and its degree of harm is very great.

Thyroid cancer is no longer cancer".

It is a rumor that has been misread and misrepresented by the public.

The professor explained that in recent years, with the increasing number of thyroid cancer patients, the debate over whether or not to operate for thyroid microcarcinoma and the scope of surgery has become more and more intense. Thyroid microcarcinoma is a thyroid tumor with a tumor diameter of less than 1 cm. After a tiny cancer is found, most people choose surgery immediately.

So, microcarcinoma shouldn't be all over the place.

Microcarcinoma is not the same as early-stage cancer, and some patients with microcarcinoma have lymph node metastasis at the time of consultation, and some microcarcinoma is a clinically highly aggressive tumor.

For some low-risk thyroid microcarcinomas, through the judgment of professional doctors, considering the patient's own wishes and the severity of the disease, it is completely possible to consider temporary surgery, and close observation and follow-up can be taken.

1. Clinical examination of thyroid cancer.

1. If there is a history of X-ray irradiation of the head and neck in the past, male and pediatric patients have a high possibility of cancer, and 50% of thyroid nodules in childhood are cancerous, so they should be vigilant. A family history of multiple endocrine neoplasia often suggests medullary thyroid cancer.

2. Sudden increase in a short period of time. Thyroid tumors, nodular goiters and other malignant tumors can become anaplastic thyroid carcinomas, and the mass can suddenly enlarge in a short period of time. However, it should be noted that benign thyroid cystadenoma can be combined with intracapsular hemorrhage, or it can be manifested as a sudden increase in a short period of time, and attention should be paid to differentiation.

3. Symptoms of compression, such as hoarseness or difficulty breathing.

4. Evidence of invasion or infiltration of adjacent tissues; or dispersed, swollen, solid lymph nodes. The tumor is hard and the surface is rough and uneven.

5. The tumor activity is limited or fixed, and it does not move up and down with swallowing, and the symptoms of compression are combined.

6. Cervical lymphadenopathy. In some cases, lymph node aspiration can aspirate a yellowish fluid.

2. Puncture cytology.

Diagnosis is often confirmed by using fine-needle aspiration biopsy (FNAB) of the primary lesion or cervical lymph nodes. Since FNAB is only diagnosed from a cytological point of view, it is difficult to classify the tumor tissues. In cases of cervical lymphadenopathy, cervical lymph node biopsy or frozen biopsy may also be done.

3. X-ray examination.

X-rays of the anterolateral neck may show calcified (sand granular) foci, tracheal compression, and displacement within thyroid tumors. Barium swallow test to help determine whether the esophagus is affected. Chest x-ray may reveal metastases to the upper mediastinum and lungs.